Huang Xu, Liu Jianhua, Wang Huiming, Zhu Huiyong, Li Zhiyong, Teng Lisong
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Feb;28(2):192-6.
To investigate the clinical outcomes of resection of mandibular benign tumors and primary reconstruction with autogenous bone graft via an intraoral approach.
Fifteen patients with mandibular benign tumors were treated between January 2009 and September 2012. There were 7 males and 8 females, aged from 18 to 45 years (mean, 30 years). The pathological diagnosis identified 11 cases of ameloblastoma, 3 cases of odontogenic keratocyst, and 1 case of odontogenic myxoma. According to the Urken's CRBS (Condyle, Ramus, Body, Symphysis) classification criteria based on the location of the mandibular defect, there were 3 cases of body type (B type), 3 cases of ramus type (R type), and 9 cases of body and ramus type (BR type). The surgeries were performed via an intraoral approach, except 1 patient with the lesion at the level of sigmoid notch via an auxiliary preauricular incision. To fix the bone grafts to the dissected mandibular defects, reconstructive titanium plates were used, either indirectly according to the computer aided design/computer aided manufacturing mandibular models before surgery (9 patients) or directly according to the exposed mandibles during surgery (6 patients). The patients received benign mandibular tumor resection and primary autogenous bone graft reconstruction with free iliac bones (11 cases) or vascularized fibular flaps (4 cases). The mandibular inferior alveolar nerves were preserved in 6 cases.
Primary healing of incision was obtained in 14 patients, while secondary healing in 1 patient suffering from bone graft infection. All the patients were followed up 1-4 years (mean, 2.5 years). At last follow-up, no patients showed facial nerve damage; occlusion of remaining teeth was similar to preoperative conditions; the chewing function was satisfactory; mouth opening was 30-35 mm (mean, 33 mm); and swallowing and speaking functions were normal. Only slight extraoral scars caused by the auxiliary incision and the transbuccal appliances were observed, and all the patients were satisfied with the facial appearance. Lower lip numbness was relived in patients with preserved inferior alveolar nerves. There was no tumor recurrence during follow-up period.
The intraoral approach is a feasible and proper approach for resection of benign mandibular tumors and primary reconstruction with autogenous bone grafts, with the advantages of inconspicuous facial scars, minimum damage to the facial nerve, and expectable aesthetic appearance.
探讨经口内入路切除下颌骨良性肿瘤并采用自体骨移植进行一期重建的临床效果。
2009年1月至2012年9月期间,对15例下颌骨良性肿瘤患者进行治疗。其中男性7例,女性8例,年龄18至45岁(平均30岁)。病理诊断为成釉细胞瘤11例、牙源性角化囊肿3例、牙源性黏液瘤1例。根据基于下颌骨缺损部位的Urken's CRBS(髁突、升支、体部、颏部)分类标准,体部型(B型)3例,升支型(R型)3例,体部和升支型(BR型)9例。除1例病变位于乙状切迹水平的患者经辅助耳前切口外,其余手术均经口内入路进行。为将骨移植固定于解剖后的下颌骨缺损处,采用重建钛板,9例患者术前根据计算机辅助设计/计算机辅助制造下颌模型间接固定,6例患者术中根据暴露的下颌骨直接固定。患者接受下颌骨良性肿瘤切除及一期自体骨移植重建,采用游离髂骨(11例)或带血管蒂腓骨瓣(4例)。6例患者保留了下颌下牙槽神经。
14例患者切口一期愈合,1例骨移植感染患者二期愈合。所有患者均随访1至4年(平均2.5年)。末次随访时,无患者出现面神经损伤;余牙咬合与术前相似;咀嚼功能良好;开口度为30至35毫米(平均33毫米);吞咽及言语功能正常。仅观察到辅助切口和经颊装置导致的轻微口外瘢痕,所有患者对面部外观满意。保留了下牙槽神经的患者下唇麻木症状缓解。随访期间无肿瘤复发。
经口内入路是切除下颌骨良性肿瘤并采用自体骨移植进行一期重建的一种可行且合适的方法,具有面部瘢痕不明显、对面神经损伤最小以及美观效果可期等优点。